Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT07078890
Recruiting Not applicable

Effect of Bone Augmentation Simultaneous to Implant Removal on the Prognosis of Reimplantation at the Same Site

NCT07078890 · tracked via the Priya Life Science China tracker
Sponsor
The Dental Hospital of Zhejiang University School of Medicine
Phase
Not applicable
Started
2025-03-12
Last updated
2025-07-22

Condition(s) studied

Implant FailureBone AugmentationPrognosis

Investigational drug(s) / intervention(s)

bone augmentation simultaneous to implant removal

bone augmentation simultaneous to implant removal: Placement of bone substitutes in the socket simultaneous to implant removal, and reimplantation is performed after 6 months of healing.

Study summary

The aim of this study was to investigate the effect of bone augmentation simultaneous to implant removal on the prognosis of reimplantation at the same sites, providing recommendations for management strategies after failed implant removal.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * 1\. Age greater than 18 years 2. Implant failure requiring removal 3. Plan to reimplant in the same site 4. Periodontal health, or stabilized periodontitis after treatment Exclusion Criteria: * 1\. Uncontrolled metabolic diseases 2. Taking medications that have an effect on bone metabolism 3. The implant has detached at the time of consultation 4. Do not consent to reimplant in the same site 5. Unwillingness to participate in the follow-up of this study 6. Other conditions that do not qualify for implant therapy

Primary outcome measure(s)

  • Ridge Height (RH) — Before implant removal and 6 months after implant removal
    Two reference lines were established for the radiological analysis: the longitudinal axis of the implant and a line perpendicular to this axis and tangential to a reference point (sinus floor in the maxilla and mandibular base in the mandible).Ridge height (RH) in mm, defined as the distance between the tangential reference line and the most coronal point of the bone crest, assessed buccal (B-RH) and lingual (L-RH).

Trial sites (3)

FacilityCityRegionStatus
Hospital of Stomatology, Wuhan University Wuhan Hubei Recruiting
The Affiliated Stomatology Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang Recruiting
Shanghai Stomatological Hospital Shanghai China Recruiting

More The Dental Hospital of Zhejiang University School of Medicine trials in China

The Study on the Accuracy of Peri-implant Probing and Related Influencing Factors Recruiting
The Impact of the Adequacy of Keratinized Mucosa on Peri-implant Tissue Health and Patient-reported Outcomes Recruiting
Clinical Application Strategies of Maxillary Sinus Buccal Bony Window Recruiting
Site Preservation Was Performed Through an Open Healing Oral Restorative Membrane Starting soon
In Vivo Study on the Material Properties of iRoot SP and nRoot SP Root Canal Sealers Recruiting

Other trials for the same condition

Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy Recruiting
Molecular Subtype-Guided Postoperative Radiotherapy for Phyllodes Tumor of the Breast Starting soon
Validation of RCC Predicting Model With Emulated-target Trial Recruiting
Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics Starting soon
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07078890 on ClinicalTrials.gov ↗ ← All trials in China